The total return over the past 12 months is -59.59% vs. +16.94% for the S&P 500. So far it's up -67.20% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (59.59%) | (4.35%) | (31.70%) | N/A | N/A | N/A |
| Total Return CAGR | (59.59%) | (4.35%) | (31.70%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Fulcrum Therapeutics, Inc. (FULC)
| Year | Start price | End price | FULC Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $11.31 | $3.71 | (67.20%) | +14.51% | (81.71%) |
| 2025 | $4.70 | $11.31 | +140.64% | +17.72% | +122.92% |
| 2024 | $6.75 | $4.70 | (30.37%) | +24.89% | (55.26%) |
| 2023 | $7.28 | $6.75 | (7.28%) | +26.19% | (33.47%) |
| 2022 | $17.69 | $7.28 | (58.85%) | (18.17%) | (40.68%) |
| 2021 | $11.71 | $17.69 | +51.07% | +28.74% | +22.33% |
| 2020 | $16.64 | $11.71 | (29.63%) | +18.37% | (48.00%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
